{"analyses":[{"ciNumSides":"TWO_SIDED","ciPctValue":"95","groupIds":["OG000","OG001","OG002"],"nonInferiorityType":"SUPERIORITY_OR_OTHER_LEGACY","pValue":"0.0939","paramType":"Slope","paramValue":"-0.0557","statisticalMethod":"Regression, Logistic"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"20","value":"7"},{"groupId":"OG001","lowerLimit":"0","upperLimit":"39","value":"7"},{"groupId":"OG002","lowerLimit":"0","upperLimit":"35","value":"7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"117"},{"groupId":"OG001","value":"103"},{"groupId":"OG002","value":"129"}],"units":"Participants"}],"description":"A logistic regression model will be used to test the ability of the number of days of neutropenia to predict the presence of a polymorphism.","dispersionType":"Full Range","groups":[{"description":"Induction therapy + single myeloablative consolidation","id":"OG000","title":"Single HST (CEM)"},{"description":"Induction therapy + tandem myeloablative consolidation","id":"OG001","title":"Tandem HST (CEM), Randomly Assigned"},{"description":"Patients that either failed during Induction therapy or refused randomization","id":"OG002","title":"Not Assigned"}],"paramType":"MEDIAN","populationDescription":"Eligible patients with available polymorphism and neutropenia toxicity data.","reportingStatus":"POSTED","timeFrame":"Through completion of a participant's first cycle during induction, including treatment delays, assessed up to 39 days","title":"Duration of Greater Than or Equal to Grade 3 Neutropenia","type":"SECONDARY","unitOfMeasure":"Days"}